Albiol, N, Moreno, C. Autoimmune Cytopenia in CLL Prognosis and Management in the Era of Targeted Therapies. CANCER JOURNAL. 2021; 27(4)DOI:10.1097/PPO.0000000000000537. PMID:34398555. IF:2.074(Q4/9D).

Esquirol, A, Pascual, MJ, Garcia-Cadenas, I, Herruzo, B, Ferra, C, Perez, A, Torio, A, Torrent, A, Cuesta, M, Martino, R, Sierra, J. Combining Three Different Pretransplantation Scores Improves Predictive Value in Patients after Haploidentical Stem Cell Transplantation with Thiotepa, Busulfan, and Fludarabine Conditioning and Post-Transplantation Cyclophosphamide. Transplantation And Cellular Therapy. 2021; 27(7)DOI:10.1016/j.jtct.2021.03.021. PMID:33775908. IF:(Q/D).

Greil, R, Tedeschi, A, Moreno, C, Anz, B, Larratt, L, Simkovic, M, Gill, D, Gribben, JG, Flinn, IW, Wang, ZY, Cheung, LWK, Nguyen, AN, Zhou, C, Styles, L, Demirkan, F. Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study. ANNALS OF HEMATOLOGY. 2021; 100(7)DOI:10.1007/s00277-021-04536-6. PMID:34018029. IF:4.030(Q2/5D).

Ribera, JM, Garcia, O, Buendia-Urena, B, Terol, MJ, Vicent, A, Vall-Llovera, F, Bergua, J, Garcia-Cadenas, I, Esteve, J, Ribera, J, Acuna-Cruz, E, Herrera, P, Hernandez-Rivas, JM, Abrisqueta, P, Gonzalez-Campos, J, Rodriguez, C, Bastos-Oreiro, M, Genesca, E, Caminos, N, de Llano, MPQ, Cladera, A, Sancho, JM. Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain. LEUKEMIA & LYMPHOMA. 2022; 63(8)DOI:10.1080/10428194.2022.2053531. PMID:35343365. IF:2.600(Q3/7D).